ArticleComputational and structural biotechnology journal2025
An artificial intelligence-based platform for personalized predictions of Metacognitive Training effectiveness.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Examining sex as a potential moderator of metacognitive training for psychosis efficacy on cognitive insight and jumping to conclusions bias: Evidence from a large-scale harmonized database.Schizophrenia research. Cognition · 2026Article
- From Biomedical Datasets to Fairness-Aware Recommendations: An Integrated Data Orchestration Pipeline for Binary Clinical Predictions.Computational and structural biotechnology journal · 2026Article
- PERMEPSY: a multicentre, randomized, double-blind proof-of-concept trial of personalized metacognitive training for adults with psychosis - a study protocol.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study introduces a machine learning (ML)-based platform aimed at predicting the effectiveness of Metacognitive Training (MCT). The platform is meant to function as an experimental prototype in the scope of a clinical research project for a decision support system to assist clinicians in tailoring treatment plans for patients with psychosis. It integrates eight ML models to evaluate MCT effectiveness under a wide range of mental health questionnaires to assess a broad spectrum of psychological symptoms. By incorporating diverse measures, the platform aims to capture a comprehensive understanding of patient profiles, enabling more precise and tailored predictions for treatment personalization. Furthermore, the transparency requirements for artificial intelligence (AI) systems, as outlined in the AI Act regulation of the European Union, are addressed through the implementation of explainable AI models, using post-hoc explanations based on SHAP analysis for each predictive model. Ethical concerns related to ensuring gender-neutral behavior in the system are tackled by conducting a disparate impact analysis, which evaluates biases present in the models enhancing the system's accountability and alignment with ethical and regulatory standards.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.